Fosapp contains Fosaprepitant, a neurokinin-1 (NK1) receptor antagonist used primarily as an antiemetic to prevent nausea and vomiting caused by chemotherapy. Fosaprepitant is the prodrug of aprepitant, which works by blocking the effects of substance P, a neurotransmitter involved in vomiting reflex.
Chemotherapy-Induced Nausea and Vomiting (CINV):
Postoperative Nausea and Vomiting (PONV):
Fosaprepitant is rapidly converted to aprepitant in the body, which selectively inhibits the neurokinin-1 receptor. This blockage prevents the action of substance P in the central nervous system, thereby reducing nausea and vomiting.
Chemotherapy-Induced Nausea and Vomiting (CINV):
Postoperative Nausea and Vomiting (PONV):
Fosapp is used to treat the following -
Main Benefits
Fosapp should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Fosapp unless your doctor advises you to do so -
Is this Fosapp habit forming or addictive?
No, you will not get addicted to Fosapp.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience